Related references
Note: Only part of the references are listed.Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer
Theodoros Karantanos et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
Felix Klug et al.
CANCER CELL (2013)
Reactivation of the Silenced Thyroid Hormone Receptor β Gene Expression Delays Thyroid Tumor Progression
Won Gu Kim et al.
ENDOCRINOLOGY (2013)
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2
Likun Li et al.
MOLECULAR ONCOLOGY (2013)
Multivariate Analysis of the Relationship Between Male Sex, Disease-Specific Survival, and Features of Tumor Aggressiveness in Thyroid Cancer of Follicular Cell Origin
Naris Nilubol et al.
THYROID (2013)
Diabetes and Thyroid Cancer Risk: Literature Review
Shyang-Rong Shih et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Inflammation and immune surveillance in cancer
Melvyn T. Chow et al.
SEMINARS IN CANCER BIOLOGY (2012)
Obesity and Thyroid Cancer Risk among US Men and Women: A Pooled Analysis of Five Prospective Studies
Cari M. Kitahara et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
GLIPR1 Suppresses Prostate Cancer Development through Targeted Oncoprotein Destruction
Likun Li et al.
CANCER RESEARCH (2011)
GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy
Guru Sonpavde et al.
CLINICAL CANCER RESEARCH (2011)
Diabetes and Thyroid Cancer Risk in the National Institutes of Health-AARP Diet and Health Study
Briseis Aschebrook-Kilfoy et al.
THYROID (2011)
Impact of gender on bladder cancer incidence, staging, and prognosis
Harun Fajkovic et al.
WORLD JOURNAL OF UROLOGY (2011)
CCL5 as an adjuvant for cancer immunotherapy
Natalia Lapteva et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity
Anna Ruggieri et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Thyroid cancer and inflammation
Valentina Guarino et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences
Hayato Nakagawa et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling
Likun Li et al.
CANCER RESEARCH (2008)
Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry
Xia Xu et al.
ANALYTICAL CHEMISTRY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Unlimited access to care: Effect on racial disparity and prognostic factors in lung cancer
CR Mulligan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer
T Satoh et al.
HUMAN GENE THERAPY (2003)
Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma:: A mouse model of thyroid carcinogenesis
H Suzuki et al.
THYROID (2002)
mRTVP-1, a novel p53 target gene with proapoptotic activities
CH Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited
E Kebebew et al.
WORLD JOURNAL OF SURGERY (2001)
Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone
M Kaneshige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
